Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocol - Schubert, Maria-Luisa; Schmitt, Anita; Sellner, Leopold; Neuber, Brigitte; Kunz, Joachim; Wuchter, Patrick; Kunz, Alexander; Gern, Ulrike; Michels, Birgit; Hofmann, Susanne; Hückelhoven-Krauss, Angela; Kulozik, Andreas; et al. (BMJ open, 2019)
First published on May 19, 2019